BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 21909730)

  • 1. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial.
    Grimnes G; Joakimsen R; Figenschau Y; Torjesen PA; Almås B; Jorde R
    Osteoporos Int; 2012 Jan; 23(1):201-11. PubMed ID: 21909730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women.
    Macdonald HM; Wood AD; Aucott LS; Black AJ; Fraser WD; Mavroeidi A; Reid DM; Secombes KR; Simpson WG; Thies F
    J Bone Miner Res; 2013 Oct; 28(10):2202-13. PubMed ID: 23585346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension.
    Zhang ZL; Liao EY; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; De Peng Y; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L; Santora AC
    Osteoporos Int; 2015 Sep; 26(9):2365-74. PubMed ID: 25929192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of dietary calcium intake and vitamin D status on the effects of zoledronate.
    Bourke S; Bolland MJ; Grey A; Horne AM; Wattie DJ; Wong S; Gamble GD; Reid IR
    Osteoporos Int; 2013 Jan; 24(1):349-54. PubMed ID: 22893357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.
    Zhu HM; Qin L; Garnero P; Genant HK; Zhang G; Dai K; Yao X; Gu G; Hao Y; Li Z; Zhao Y; Li W; Yang J; Zhao X; Shi D; Fuerst T; Lu Y; Li H; Zhang X; Li C; Zhao J; Wu Q; Zhao SJ
    Osteoporos Int; 2012 Apr; 23(4):1317-27. PubMed ID: 21505910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength: A Randomized Clinical Trial.
    Burt LA; Billington EO; Rose MS; Raymond DA; Hanley DA; Boyd SK
    JAMA; 2019 Aug; 322(8):736-745. PubMed ID: 31454046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial.
    Hansen KE; Johnson RE; Chambers KR; Johnson MG; Lemon CC; Vo TN; Marvdashti S
    JAMA Intern Med; 2015 Oct; 175(10):1612-21. PubMed ID: 26237520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis.
    Nakamura T; Matsumoto T; Sugimoto T; Shiraki M
    Osteoporos Int; 2012 Mar; 23(3):1131-40. PubMed ID: 21927920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China.
    Liao EY; Zhang ZL; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; Peng YD; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L
    Medicine (Baltimore); 2018 Aug; 97(31):e11694. PubMed ID: 30075569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial.
    Pop LC; Sukumar D; Schneider SH; Schlussel Y; Stahl T; Gordon C; Wang X; Papathomas TV; Shapses SA
    Osteoporos Int; 2017 Jan; 28(1):377-388. PubMed ID: 27535752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of high-dose vitamin D
    Larsen AU; Grimnes G; Jorde R
    Osteoporos Int; 2018 Jan; 29(1):171-180. PubMed ID: 28921338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Vitamin D Supplementation on Bone Mass in Infants With 25-Hydroxyvitamin D Concentrations Less Than 50 nmol/L: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Gharibeh N; Razaghi M; Vanstone CA; Sotunde OF; Glenn L; Mullahoo K; Farahnak Z; Khamessan A; Wei SQ; McNally D; Rauch F; Jones G; Kaufmann M; Weiler HA
    JAMA Pediatr; 2023 Apr; 177(4):353-362. PubMed ID: 36780180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
    Cheung AM; Tile L; Lee Y; Tomlinson G; Hawker G; Scher J; Hu H; Vieth R; Thompson L; Jamal S; Josse R
    PLoS Med; 2008 Oct; 5(10):e196. PubMed ID: 18922041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
    Nahas-Neto J; Cangussu LM; Orsatti CL; Bueloni-Dias FN; Poloni PF; Schmitt EB; Nahas EAP
    Osteoporos Int; 2018 May; 29(5):1125-1133. PubMed ID: 29450585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year.
    Jorde R; Sneve M; Torjesen PA; Figenschau Y; Hansen JB; Grimnes G
    Nutr J; 2010 Jan; 9():1. PubMed ID: 20056003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.